Tirzepatide Canada — available through Vancouver Island Peptides, synthesized domestically at our Vancouver, BC lab partner. Our Tirzepatide in Canada is produced locally, not sourced from overseas and repackaged. Research-grade purity, full traceability, shipped discreetly Canada-wide.
Available in 10mg and 30mg lyophilized powder vials.
Tirzepatide is a synthetic peptide and dual GLP-1/GIP receptor agonist that has become one of the most studied metabolic research compounds in the world. By simultaneously targeting two complementary hormone receptors, Tirzepatide produces effects on appetite regulation, insulin sensitivity, and metabolic rate that exceed single-agonist compounds like Semaglutide.
As a domestic peptide in Canada, our Tirzepatide is produced under the same strict quality standards as all Vancouver Island Peptides compounds — synthesized in British Columbia, not imported.
The dual mechanism is what distinguishes Tirzepatide from earlier single-agonist GLP-1 compounds, and it remains the established benchmark for dual-agonist metabolic research in Canada and globally.
| Product Name | Tirzepatide |
| Format | Lyophilized Powder |
| Available Sizes | 10mg, 20mg |
| Purity | >99% (HPLC verified) |
| Storage | −20°C, away from light |
| Origin | Domestic — Vancouver, BC, Canada |
| Shipping | Canada-wide, discreet packaging |
| Payment | Bitcoin (BTC) |
Both are available as domestic peptides Canada through Vancouver Island Peptides. Tirzepatide is the established dual-agonist with the longer research history. Retatrutide extends this with a third receptor target (glucagon), offering broader metabolic coverage. Researchers often start with Tirzepatide as the baseline comparator.
View Tirzepatide on the Store